A remote early-intervention program may boost development in preterm infants — a trial puts it to the test
NCT ID NCT07727733
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether a child-centered, family-based early intervention program called HEP (Homeostasis-Enrichment-Plasticity) can improve motor, cognitive, language, and social-emotional skills when delivered via tele-rehabilitation to preterm infants at developmental risk. The study enrolls infants born at or before 36 weeks and 6 days of gestation, with a corrected age between 4 and 12 months. Families participate from home, and the program is grounded in theories of environmental enrichment and neuroplasticity.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a child-centered, family-based early intervention program called HEP (Homeostasis-Enrichment-Plasticity) delivered via tele-rehabilitation
- What this could lead to
- If it works, this could offer a practical, home-based way to support the development of preterm infants who are at risk for delays.
- What could go wrong
- This is a small feasibility study with only 16 infants, so results may not apply broadly. The program requires active family participation, which may be challenging for some.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
16 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 12 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Infants with a corrected age between 4 and 12 months. * Infants born at or before 36 weeks and 6 days of gestation. * Infants with no congenital anomalies. * Families who agree to participate regularly in the study process. Exclusion Criteria: * Infants with major visual or hearing impairments. * Infants with any genetic syndrome or congenital anomalies. * Infants with medical conditions that prevent active participation in the study (e.g., oxygen dependence). * Infants participating in other experimental rehabilitation studies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Preterm infants at developmental risk are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sense On , Istanbul, Beykoz 34810
Istanbul, Beykoz, 34810, Turkey (Türkiye)